Home › Companies › Orchestra Biomed Holdings, Inc. › 2025-2026
At Orchestra Biomed Holdings, Inc.'s shareholder meeting held June 23, 2026, in the 2025-2026 proxy season, 57 asset managers reported how they voted in their SEC Form N-PX filings, covering 317 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Adoption of an advisory (non-binding) resolution approving the compensation of our "named… — Orchestra Biomed Holdings, Inc.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Orchestra Biomed Holdings, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 23, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Orchestra Biomed Holdings, Inc.’s Form 8-K, filed June 23, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 23, 2026: 6 items on Orchestra Biomed Holdings, Inc.’s Form 8-K, filed June 23, 2026: 3 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Orchestra Biomed Holdings, Inc. in the interactive database Compare manager voting policies
These tallies are Orchestra Biomed Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 23, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: David P. Hochman | 39,724,691 | -- | -- | 97,018 | 9,231,589 | 99.7% | Elected | — |
| Elect Director: Darren R. Sherman | 39,544,240 | -- | -- | 277,469 | 9,231,589 | 99.3% | Elected | — |
| Elect Director: Eric S. Fain | 37,810,358 | -- | -- | 2,011,351 | 9,231,589 | 95% | Elected | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm The proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026 (t | 49,039,578 | 13,692 | 28 | -- | -- | 99.9% | Approved | — |
| 3. Approval of the Orchestra BioMed Holdings, Inc. 2026 Employee Stock Purchase Plan The proposal to approve the Orchestra BioMed Holdings, Inc. 2026 Equity Incentive Plan (the "ESPP Proposal") | 39,639,592 | 150,243 | 31,874 | -- | 9,231,589 | 99.6% | Approved | — |
| 4. Advisory, Non-Binding Vote on the Compensation of the Company's Named Executive Officers The advisory (non-binding) vote on the compensation of the Company's named executive officers (the "NEOs"), as set forth in the Proxy Statement, received the following | 37,975,986 | 1,778,200 | 67,523 | -- | 9,231,589 | 96% | Approved | — |
Source: Orchestra Biomed Holdings, Inc., Form 8-K, filed with the SEC on June 23, 2026 — read the filing on EDGAR.
Each item below shows how the 57 asset managers that disclosed a Orchestra Biomed Holdings, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Orchestra Biomed Holdings, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Darren Sherman
Orchestra Biomed Holdings, Inc.’s own tally for this item (“Elect Director: Darren R. Sherman”): 39,544,240 for, 277,469 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1: Election of Directors Votes regarding the election of the three Class III director nominees were as follows: Based on the votes set forth above, the Company's stockholders elected each of the three nominees set forth above to serve as a Class III director of the Company until the Co…”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 14 asset managers below reported 3,332,922 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,069,778 | 0 | 0 | 0 | For |
| Fidelity | 393,713 | 0 | 0 | 0 | For |
| Charles Schwab | 265,569 | 0 | 0 | 0 | For |
| BlackRock | 252,972 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 219,387 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 63,500 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 31,238 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,612 | 0 | 0 | 0 | For |
| Northern Trust | 8,764 | 0 | 0 | 0 | For |
| Equitable | 7,348 | 0 | 0 | 0 | For |
| American Century | 3,182 | 0 | 0 | 0 | For |
| ProShares | 2,298 | 0 | 0 | 0 | For |
| Invesco | 1,283 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 278 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: David Hochman
Orchestra Biomed Holdings, Inc.’s own tally for this item (“Elect Director: David P. Hochman”): 39,724,691 for, 97,018 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1: Election of Directors Votes regarding the election of the three Class III director nominees were as follows: Based on the votes set forth above, the Company's stockholders elected each of the three nominees set forth above to serve as a Class III director of the Company until the Co…”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 14 asset managers below reported 3,332,922 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,069,778 | 0 | 0 | 0 | For |
| Fidelity | 393,713 | 0 | 0 | 0 | For |
| Charles Schwab | 265,569 | 0 | 0 | 0 | For |
| BlackRock | 252,972 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 219,387 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 63,500 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 31,238 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,612 | 0 | 0 | 0 | For |
| Northern Trust | 8,764 | 0 | 0 | 0 | For |
| Equitable | 7,348 | 0 | 0 | 0 | For |
| American Century | 3,182 | 0 | 0 | 0 | For |
| ProShares | 2,298 | 0 | 0 | 0 | For |
| Invesco | 1,283 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 278 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Eric Fain
Orchestra Biomed Holdings, Inc.’s own tally for this item (“Elect Director: Eric S. Fain”): 37,810,358 for, 2,011,351 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1: Election of Directors Votes regarding the election of the three Class III director nominees were as follows: Based on the votes set forth above, the Company's stockholders elected each of the three nominees set forth above to serve as a Class III director of the Company until the Co…”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 14 asset managers below reported 3,031,406 for, 301,509 withheld, 7 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,069,771 | 0 | 7 | 0 | For |
| Fidelity | 393,713 | 0 | 0 | 0 | For |
| Charles Schwab | 265,569 | 0 | 0 | 0 | For |
| BlackRock | 29,207 | 0 | 0 | 223,765 | Mixed |
| Simplify Exchange Traded Funds | 219,387 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 63,500 | Withhold |
| CLEARWATER INVESTMENT TRUST | 31,238 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,612 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 8,764 | Withhold |
| Equitable | 7,348 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 3,182 | Withhold |
| ProShares | 0 | 0 | 0 | 2,298 | Withhold |
| Invesco | 1,283 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 278 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Approval of the Orchestra BioMed Holdings, Inc. 2026 Employee Stock Purchase Plan.
Orchestra Biomed Holdings, Inc.’s own tally for this item (“3. Approval of the Orchestra BioMed Holdings, Inc. 2026 Employee Stock Purchase Plan The proposal to approve the Orchestra BioMed Holdings, Inc. 2026 Equity Incentive Plan (the "ESPP Proposal") received the following vot”): 39,639,592 for, 150,243 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the ESPP Proposal was approved.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 14 asset managers below reported 3,332,921 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,069,777 | 0 | 0 | 0 | For |
| Fidelity | 393,713 | 0 | 0 | 0 | For |
| Charles Schwab | 265,569 | 0 | 0 | 0 | For |
| BlackRock | 252,972 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 219,387 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 63,500 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 31,238 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,612 | 0 | 0 | 0 | For |
| Northern Trust | 8,764 | 0 | 0 | 0 | For |
| Equitable | 7,348 | 0 | 0 | 0 | For |
| American Century | 3,182 | 0 | 0 | 0 | For |
| ProShares | 2,298 | 0 | 0 | 0 | For |
| Invesco | 1,283 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 278 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: Adoption of an advisory (non-binding) resolution approving the compensation of our "named executive officers".
Orchestra Biomed Holdings, Inc.’s own tally for this item (“4. Advisory, Non-Binding Vote on the Compensation of the Company's Named Executive Officers The advisory (non-binding) vote on the compensation of the Company's named executive officers (the "NEOs"), as set forth in the ”): 37,975,986 for, 1,778,200 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the Company's stockholders approved, on an advisory basis, the compensation of the NEOs.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,069,771 | 6 | 0 | 0 | For |
| Fidelity | 393,713 | 0 | 0 | 0 | For |
| Charles Schwab | 265,569 | 0 | 0 | 0 | For |
| BlackRock | 252,972 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 219,387 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 63,500 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 31,238 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,612 | 0 | 0 | 0 | For |
| Northern Trust | 8,764 | 0 | 0 | 0 | For |
| Equitable | 7,348 | 0 | 0 | 0 | For |
| American Century | 0 | 3,182 | 0 | 0 | Against |
| ProShares | 0 | 2,298 | 0 | 0 | Against |
| Invesco | 0 | 1,283 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 278 | 0 | 0 | 0 | For |
Fund voting reports, all 14 managers: 3,262,652 for, 70,269 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 2,869,489 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,099,900 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 1,000,000 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 485,492 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 337,329 | 0 | 0 | 0 | For |
| Charles Schwab | 265,593 | 0 | 0 | 0 | For |
| Knott David M Jr | 0 | 253,651 | 0 | 0 | Against |
| Vanguard | 249,162 | 1,523 | 0 | 0 | For |
| BlackRock | 205,470 | 0 | 0 | 0 | For |
| State Street | 171,787 | 3,263 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 139,113 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 126,841 | 0 | 0 | 0 | For |
| Northern Trust | 90,542 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 70,600 | 0 | 0 | Against |
| Neuberger Berman | 68,730 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 0 | 55,000 | 0 | 0 | Against |
| Renaissance | 0 | 50,053 | 0 | 0 | Against |
| Point72 | 0 | 45,773 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 30,699 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 0 | 21,100 | 0 | 0 | Against |
| Corient Private Wealth LP | 0 | 18,275 | 0 | 0 | Against |
| HighTower Advisors, LLC | 0 | 18,275 | 0 | 0 | Against |
| Frec Advisers LLC | 13,048 | 0 | 0 | 0 | For |
| FIRST CITIZENS BANK & TRUST CO | 0 | 6,489 | 6,489 | 0 | Mixed |
| MELLON INVESTMENTS Corp | 0 | 12,784 | 0 | 0 | Against |
Institutional-manager reports, all 48 managers: 6,173,045 for, 1,594,044 against, 6,489 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Advisory (non-binding) vote on the frequency of future advisory (non-binding) votes on the compensation of our "named executive officers".
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Simplify Exchange Traded Funds | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 14 managers: 3,332,858 1 year, 64 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 2,869,489 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| Alyeska Investment Group, L.P. | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Affinity Asset Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Knott David M Jr | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| RICE HALL JAMES & ASSOCIATES, LLC | 0 | 0 | 0 | 0 | -- |
| DAFNA Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Neuberger Berman | 0 | 0 | 0 | 0 | -- |
| 683 Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| CANADA PENSION PLAN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
| Corient Private Wealth LP | 0 | 0 | 0 | 0 | -- |
| HighTower Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| Frec Advisers LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Hudson Bay Capital Management LP | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 47 managers: 2,869,489 for, 4,892,892 1 year. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2026.
Orchestra Biomed Holdings, Inc.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's”): 49,039,578 for, 13,692 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the Auditor Ratification Proposal was approved.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 14 asset managers below reported 3,332,922 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,069,778 | 0 | 0 | 0 | For |
| Fidelity | 393,713 | 0 | 0 | 0 | For |
| Charles Schwab | 265,569 | 0 | 0 | 0 | For |
| BlackRock | 252,972 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 219,387 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 63,500 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 31,238 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,612 | 0 | 0 | 0 | For |
| Northern Trust | 8,764 | 0 | 0 | 0 | For |
| Equitable | 7,348 | 0 | 0 | 0 | For |
| American Century | 3,182 | 0 | 0 | 0 | For |
| ProShares | 2,298 | 0 | 0 | 0 | For |
| Invesco | 1,283 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 278 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 59,880,715 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.46% |
| 2 | Fidelity | 0.66% |
| 3 | Charles Schwab | 0.44% |
| 4 | BlackRock | 0.42% |
| 5 | Simplify Exchange Traded Funds | 0.37% |
| 6 | BRIDGEWAY FUNDS INC | 0.11% |
| 7 | CLEARWATER INVESTMENT TRUST | 0.05% |
| 8 | Goldman Sachs | 0.02% |
| 9 | Northern Trust | 0.01% |
| 10 | Equitable | 0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 4.79% |
| 2 | RTW INVESTMENTS, LP | 1.84% |
| 3 | Alyeska Investment Group, L.P. | 1.67% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.81% |
| 5 | Affinity Asset Advisors, LLC | 0.56% |
| 6 | Charles Schwab | 0.44% |
| 7 | Knott David M Jr | 0.42% |
| 8 | Vanguard | 0.42% |
| 9 | BlackRock | 0.34% |
| 10 | State Street | 0.29% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities associated with RTW Investments, LP | 19.94% | DEF14A |
| RTW Investments, LP | 19.94% | 13D |
| Medtronic plc | 16.83% | 13G |
| Perceptive Life Sciences Master Fund, Ltd. | 9.48% | DEF14A |
| Tasso Partners, LLC | 5.17% | DEF14A |
| David P. Hochman | 3.23% | DEF14A |
| Darren R. Sherman | 2.87% | DEF14A |
| Vanguard Group | 2.68% | 13F |
| Millennium Management | 1.17% | 13F |
| BlackRock | 1.06% | 13F |
Percentages above are of 59,880,715 shares outstanding, as reported by Orchestra Biomed Holdings, Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Orchestra Biomed Holdings, Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Orchestra Biomed Holdings, Inc. proxy season coverage: 2025-2026 (this page).
proxyvotesnow.com, “Orchestra Biomed Holdings (OBIO) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/orchestra-biomed-holdings-inc/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.